In the HTML and PDF versions of this article initially published online, KLRG1− should have read KLRG1+ in the first instance of the phrase in the Figure 1e legend reading “For KLRG1− NK cells, uninfected vs. OV-Q1.” In the HTML version, KLRG1− should have read KLRG1+ in the following locations: the first instance in the Figure 1b legend, the first instance in the Figure 1c legend, and the first instance in the Figure 1e legend. Finally, 1 × 105 in the Figure 5 legend should have read 1 × 105. The errors have been corrected in the print, PDF and HTML versions of this article.
Additional information
The online version of the original article can be found at https://doi.org/10.1038/nbt.4302
Rights and permissions
About this article
Cite this article
Xu, B., Ma, R., Russell, L. et al. Correction: Amendments: Publisher Correction: An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma. Nat Biotechnol 37, 102 (2019). https://doi.org/10.1038/nbt0119-102c
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0119-102c
This article is cited by
-
Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy
Journal of Translational Medicine (2023)
